|
EXOC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.90089999999132E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.182550E-04 |
| Normal-vs-Stage2 |
2.782300E-02 |
| Normal-vs-Stage3 |
9.03640000049499E-07 |
| Normal-vs-Stage4 |
1.23660000017622E-08 |
| Stage1-vs-Stage2 |
3.442800E-01 |
| Stage1-vs-Stage3 |
5.843600E-02 |
| Stage1-vs-Stage4 |
2.085000E-03 |
| Stage2-vs-Stage3 |
3.732200E-02 |
| Stage2-vs-Stage4 |
4.122000E-03 |
| Stage3-vs-Stage4 |
2.290000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.11269999994546E-06 |
| Normal-vs-AfricanAmerican |
5.237100E-03 |
| Normal-vs-Asian |
8.31000000000026E-05 |
| Caucasian-vs-AfricanAmerican |
6.747400E-01 |
| Caucasian-vs-Asian |
8.708000E-01 |
| AfricanAmerican-vs-Asian |
5.873800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.02120000003525E-06 |
| Normal-vs-Female |
2.18730000000056E-05 |
| Male-vs-Female |
1.600450E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.173290E-04 |
| Normal-vs-Age(41-60Yrs) |
3.63540000000162E-05 |
| Normal-vs-Age(61-80Yrs) |
3.37999999999727E-06 |
| Normal-vs-Age(81-100Yrs) |
5.502400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.644200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.159800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.933200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.664400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.495600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.338200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.445700E-02 |
| Classical-VS-Follicular |
6.667200E-01 |
| Classical-VS-Other |
9.829900E-02 |
| Classical-VS-Normal |
2.47279999999739E-05 |
| Tall-VS-Follicular |
1.614990E-01 |
| Tall-VS-Other |
5.297800E-01 |
| Tall-VS-Normal |
4.96620000001169E-06 |
| Follicular-VS-Other |
2.927400E-01 |
| Follicular-VS-Normal |
6.010000E-04 |
| Other-VS-Normal |
1.340800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.28399999999884E-05 |
| Normal-vs-N1 |
7.39280000550124E-08 |
| N0-vs-N1 |
1.731650E-02 |
|
|
